Mastic Gum: What the Human Trials Actually Show, and How to Choose a Capsule
Mastic gum has a long folk history and a short list of human trials behind the bottle. If you have read that it helps with stomach discomfort or breath, the useful questions are narrower than the marketing suggests: which resin, at what dose, for which outcome, and where the evidence stops. This guide covers what the research measured, how those doses map onto a capsule, and how to read a label before you buy.
What Mastic Gum Is
Mastic gum is the resin of Pistacia lentiscus var. Chia, a small evergreen shrub in the pistachio family. The plant grows around the Mediterranean, but the resin that carries the name comes from the southern half of Chios, a Greek island in the Aegean. Growers score the bark in summer, and the tree weeps tears of resin that harden into pale, translucent lumps. Those lumps are washed, sorted by size and color, and sold as mastiha.
People have chewed the resin for centuries, for the taste and for the way it settles the stomach after a meal. Modern supplements grind the same hardened resin to a powder and put it in a capsule. A traditional capsule is just milled resin, with no extract or isolate.
Much of the resin is a high-molecular-weight polymer the body does not absorb well, alongside terpenes and volatile oils. Researchers still debate which fraction does the work, and most human trials used the whole resin. That matters when buying: a product listing an extract or a mastic oil is not the material the trials used.
Why Chios Origin and Certification Matter
The word mastic is not protected everywhere. Resin from other Pistacia species, or resin cut with filler, can be sold under the same name in markets that do not enforce origin rules. Most of the human trials used Chios resin, so a bottle made from another species tells you nothing about those results.
Chios mastic carries a protected designation of origin in the European Union, and the Chios Mastiha Growers Association administers the certification mark. A serious label will say Chios Mastiha and name the association, usually with a seal. If a product says only mastic gum with no origin, you are guessing.
Certification also covers handling. The association sets grading standards, and certified resin is cleaned and sorted before milling, which reduces the chance of grit, bark fragments, or contamination. If origin and certification are not on the label or product page, assume they are absent.
The Forms of Mastic Gum
Mastic comes in five forms, and they are not interchangeable.
Capsules. Milled resin in a measured dose, usually 500 mg. This is the form to choose if you want to match a study dose, because you can count capsules. It also avoids the strong taste.
Powder. Loose milled resin in tubs. Cheap per gram, but bitter and sticky, and measuring a consistent dose takes a scale.
Chewing gum. The traditional method and the one used in oral health trials. Chewing keeps resin in contact with teeth and gums longer than a capsule does, which is why the 2003 plaque trial used gum.
Toothpaste. A newer format, used in a 2025 trial in orthodontic patients. It fits an existing routine, but the dose per brushing is small and not standardized across brands.
Essential oil. Steam-distilled from the resin for flavor and fragrance. It is a different material from milled resin, with no human trial base for internal use at supplement doses. Do not swap oil for capsules.
What the Human Evidence Shows
The evidence is uneven, so it is worth grading rather than listing. Some outcomes have a double-blind randomized trial. Some have a small pilot. Some have only laboratory or animal work, which does not tell you what will happen in a person.
Functional Dyspepsia
This is the strongest human data mastic has. A double-blind, placebo-controlled randomized trial enrolled 148 patients with functional dyspepsia and gave them 350 mg of Chios mastic three times daily, or placebo, for three weeks. Marked improvement was reported in 77% of the mastic group against 40% of the placebo group. It is small by pharmaceutical standards and has not been widely replicated, but it is a real randomized result with a clear dose. For stomach comfort after meals, this is the study that matters most. For everyday gas and bloating, our guide to managing gas and bloating covers the non-mastic options.
H. pylori
The H. pylori data are mixed. The honest summary is that mastic is interesting as an adjunct and poor as a solo treatment. A 2010 randomized pilot gave mastic alone at 350 mg or 1.05 g three times daily for 14 days. Clearance was seen in 4 of 13 and 5 of 13 participants, against 10 of 13 on standard triple therapy. That is a clear loss to antibiotics.
A 2026 single-blind pilot tested mastic as an add-on to bismuth quadruple therapy. Eradication was 85% with mastic against 67% without it, a difference that did not reach statistical significance (p = 0.19) in a study of roughly 32 people per group. The direction is encouraging, but the statistics are not there yet. Nothing here supports using mastic instead of eradication therapy, and anyone with a positive test should be treated by a clinician. For the broader medical pathway, see our guide to H. pylori and natural support.
Oral Health
The oral data are small but consistent. A 2003 pilot found that chewing mastic gum reduced plaque scores compared with a control. A 2025 randomized clinical trial in orthodontic patients found that a mastic-containing toothpaste reduced halitosis measures. A 2023 review of 14 papers found that mastic gum inhibited plaque accumulation and showed antibacterial activity, and called for further research. For plaque and breath, the form matters: gum and toothpaste put resin where the problem is, and capsules do not. For a wider look at breath, our guide to bad breath remedies covers the other evidence-based options.
Cholesterol and Fasting Glucose
A 2016 randomized controlled trial, the CHIOS-MASTIHA study, gave healthy volunteers 1 g or 2 g of crude mastic daily for eight weeks. Among 156 completers, the 1 g dose lowered total cholesterol by 11.5 mg/dL and fasting glucose by 4.5 mg/dL. The effect was stronger in participants who were overweight. These are modest shifts, not statin-sized ones, and they are not a reason to skip a lipid panel.
Inflammatory Bowel Disease
A 2019 double-blind, placebo-controlled randomized trial gave 60 patients 2.8 g of oral mastiha daily for three months. Symptom scores improved from baseline in the mastic group, and fecal lysozyme fell, while the placebo group's lactoferrin and calprotectin rose. A 2023 systematic review concluded that the signal is promising but that larger trials are needed. The research is active and the answers are not final.
Liver and Biochemical Markers
A 2007 randomized biochemical study in 133 subjects used 5 g of mastic daily for up to 18 months and reported shifts in serum liver enzymes and other parameters. The dose is far above anything a capsule user would take, and the design is not a modern placebo-controlled trial. Treat it as a tolerability signal more than an efficacy result.
Doses the Trials Used
Dose is where most mastic content goes vague. The trials did not use one dose. They used different doses for different outcomes, and the spread is wide.
| Outcome | Daily dose used | Duration | Study size |
|---|---|---|---|
| Functional dyspepsia | 350 mg, three times daily | 3 weeks | 148 patients |
| H. pylori, mastic alone | 350 mg or 1.05 g, three times daily | 14 days | 52 total (26 on mastic alone) |
| Cholesterol and fasting glucose | 1 g or 2 g | 8 weeks | 156 completers |
| Inflammatory bowel disease | 2.8 g | 3 months | 60 patients |
| Liver and biochemical markers | 5 g | Up to 18 months | 133 subjects |
Read this as a map of what was studied, not a dosing instruction. For digestive comfort, 350 mg three times daily has the best supporting trial.
The Capsule Math
A standard mastic capsule, including the Mastica line that Agape stocks, contains 500 mg of Chios mastiha. Two capsules equal 1 g. That converts the trial doses into capsule counts you can follow.
- 350 mg three times daily is a little under one capsule per dose. One capsule three times daily is about 1.5 g, roughly 40% above the dyspepsia trial dose.
- 1.05 g three times daily is about two capsules three times daily.
- 1 g daily is two capsules.
- 2 g daily is four capsules.
- 2.8 g daily is roughly five to six capsules.
- 5 g daily is ten capsules, which is why that study is a tolerability reference.
The Mastica label lists a serving of 2 capsules, which is 1 g of resin. To match a trial dose, count capsules rather than servings: 1 g is two capsules, 2 g is four, and 2.8 g is about six. Follow the directions on the bottle for routine use, and treat the trial doses as study protocols rather than a personal prescription.
Check servings per container, because value lives there. A 120-capsule bottle at two capsules daily lasts 60 days. The same bottle at six capsules daily lasts 20 days. Divide the price by total grams of resin to compare products honestly.
How to Choose a Mastic Gum Supplement
Four checks separate a serious product from a decorative one.
1. Resin identity and certification. Look for Pistacia lentiscus var. Chia, the words Chios Mastiha, and the Chios Mastiha Growers Association mark. Anything else is unverified resin.
2. Milligrams per capsule and total resin per bottle. A 500 mg capsule is standard. Multiply capsules by milligrams to get the total, then compare against the trial doses. A proprietary blend without individual amounts cannot be dosed against any study.
3. Additives and capsule material. Milled resin flows poorly, so many products add rice flour, silicon dioxide, or magnesium stearate. Those are usually harmless, but they dilute the resin. Read the inactive ingredients line.
4. Price per gram of resin. This is the only fair comparison across bottle sizes, and it exposes concentrates that claim higher potency while supplying less resin.
Independent testing for heavy metals and microbial contamination is a plus. If a brand cannot tell you where its resin came from, that is your answer.
Safety and Who Should Be Cautious
Mastic was well tolerated in the trials, with no serious adverse events reported. The EMA assessment report lists no known adverse reactions at traditional-use doses. Mild digestive upset is still possible with any resin, so start at one capsule and see how you respond.
The European Medicines Agency granted traditional-use status to mastic resin in 2016 for mild dyspeptic disorders. That is a regulatory acknowledgment of traditional use, not proof of efficacy. The same assessment noted that the trials were too small and methodologically weak to support well-established use.
There is not enough data to recommend mastic for children, during pregnancy, or while breastfeeding. This is not the moment to experiment.
One allergy caution matters. Mastic comes from the Anacardiaceae family, which includes pistachio, cashew, and mango. People with a known allergy to those foods should approach mastic carefully.
Mastic is not a replacement for H. pylori eradication therapy. If you have tested positive, the antibiotic regimen your clinician prescribes is the treatment.
See a doctor promptly for blood in the stool, unintended weight loss, persistent vomiting, difficulty swallowing, anemia, or new stomach symptoms that begin after age 45. Persistent reflux, pain that wakes you, or symptoms that keep returning also deserve a clinical review.
What the Evidence Does Not Support
Here are claims you will see that the human data do not carry.
- Cancer treatment. The cancer research is mostly laboratory and animal work. No human trial cited here shows that mastic treats cancer, and no one should delay oncology care.
- Asthma treatment. The respiratory claims rest on small, preliminary work, not a basis for managing asthma.
- Weight loss. No human trial cited here shows meaningful weight loss. The cholesterol trial saw metabolic shifts, not pounds.
- Replacing antibiotics or medical care. The H. pylori data are explicitly inferior to antibiotics when mastic is used alone. Adjunct research is not a license to skip eradication therapy.
- Curing or preventing any named disease. Mastic supports digestive comfort, a healthy microbial balance, and oral health. It does not diagnose, treat, cure, or prevent disease.
What We Recommend
Allergy Research Group, Mastica 120 Veg Capsules
Each capsule supplies 500 mg of certified Chios mastiha, and two capsules make 1 g, so trial doses are easy to follow.
$56.29
Pure Encapsulations, DGL Plus
It is a complementary gastric-comfort option to consider alongside mastic.
$27.40
The first product is the mastic pick. The other two are alternatives for the same goal, not mastic products. The Agape team can help if you are unsure which fits. Our digestive enzymes guide explains when enzymes make more sense.
Browse digestion and gut health resources or the full digestion and gastrointestinal support collection.
Frequently Asked Questions
How much mastic gum should I take daily?
For digestive comfort, the closest match is 350 mg three times daily, roughly one 500 mg capsule three times daily. The cholesterol and glucose study used 1 g to 2 g daily, or two to four capsules. Start low and give it two to three weeks.
Can mastic gum replace antibiotics for H. pylori?
No. Used alone in a 2010 pilot, it cleared the infection in far fewer people than standard triple therapy. The 2026 adjunct pilot added mastic to quadruple therapy and saw a higher eradication rate, but the difference was not statistically significant. Eradication therapy remains the treatment.
How long does mastic gum take to work?
The dyspepsia trial ran three weeks, the cholesterol trial eight weeks, and the IBD trial three months. There is no evidence for an immediate effect, so a fair trial is at least three to four weeks at a consistent dose.
Is mastic gum safe to take every day?
The trials used daily doses for weeks to months with mostly mild digestive effects, and the EMA recognizes traditional use for mild dyspeptic disorders. Data are insufficient for children, pregnancy, and breastfeeding, and people with pistachio, cashew, or mango allergy should be cautious.
Does mastic gum help with bad breath?
The oral evidence is small but positive. A 2003 pilot found reduced plaque with mastic chewing gum, and a 2025 randomized trial found a mastic toothpaste reduced halitosis measures in orthodontic patients. Gum and toothpaste were tested, not capsules.
Is mastic gum the same as pistachio?
Related but not the same. Mastic comes from Pistacia lentiscus var. Chia, while the pistachio you eat comes from Pistacia vera. Both sit in the Anacardiaceae family, which is why a pistachio allergy is a reason for caution.
References
- Dabos KJ, Sfika E, Vlatta LJ, Frantzi D, Amygdalos GI, Giannikopoulos G. Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial. Journal of Ethnopharmacology. 2010. https://pubmed.ncbi.nlm.nih.gov/19961914/
- Dabos KJ, Sfika E, Vlatta LJ, Giannikopoulos G. The effect of mastic gum on Helicobacter pylori: a randomized pilot study. Phytomedicine. 2010. https://pubmed.ncbi.nlm.nih.gov/19879118/
- Tulsian V, Kant R, Patnaik I, Khapre M, Meena K, Routhu B. Mastic gum as an adjunct to bismuth quadruple therapy for Helicobacter pylori: a randomized single-blind pilot study. Indian Journal of Gastroenterology. 2026. https://pubmed.ncbi.nlm.nih.gov/41832367/
- Takahashi K, et al. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. Journal of Periodontology. 2003. https://pubmed.ncbi.nlm.nih.gov/12747455/
- Alexiou A, Mylonopoulou IM, Papageorgiou S, Papaioannou W, Sifakakis I. The effect of Chios mastic toothpaste on halitosis and oral hygiene in orthodontic patients: a randomized clinical trial. Journal of Breath Research. 2025. https://pubmed.ncbi.nlm.nih.gov/40680773/
- Papada E, et al. Regulation of faecal biomarkers in inflammatory bowel disease patients treated with oral mastiha supplement: double-blind, placebo-controlled randomised trial. Phytotherapy Research. 2019. https://pubmed.ncbi.nlm.nih.gov/30450689/
- Kartalis A, et al. Effects of Chios mastic gum on cholesterol and glucose levels of healthy volunteers: CHIOS-MASTIHA. European Journal of Preventive Cardiology. 2016. https://pubmed.ncbi.nlm.nih.gov/26311707/
- Triantafyllou A, Chaviaras N, Sergentanis TN, Protopapa E, Tsaknis J. Chios mastic gum modulates serum biochemical parameters in a human population. Journal of Ethnopharmacology. 2007. https://pubmed.ncbi.nlm.nih.gov/17150319/
- Soulaidopoulos S, Tsiogka A, Chrysohoou C, et al. Overview of Chios mastic gum (Pistacia lentiscus) effects on human health. Nutrients. 2022. https://pubmed.ncbi.nlm.nih.gov/35276949/
- Blomquist SA, Fernandez ML. Chios mastic gum: a promising phytotherapeutic for cardiometabolic health. Nutrients. 2024. https://pubmed.ncbi.nlm.nih.gov/39275256/
- Mavroudi A, Hadjimbei E, Giannakou K, Chrysostomou S. The effect of Chios mastic supplementation in inflammatory bowel disease: a systematic literature review. Journal of Medicinal Food. 2023. https://pubmed.ncbi.nlm.nih.gov/37001176/
- Dzwonkowski M, Bahirwani J, Rollins S, et al. Selected use of complementary and alternative medicine agents in inflammatory bowel disease. Current Gastroenterology Reports. 2025. https://pubmed.ncbi.nlm.nih.gov/39821707/
- European Medicines Agency. Assessment report on Pistacia lentiscus L., resin (mastix). 2016.
- Floris S, Di Petrillo A, Pintus F, Delogu GL. Pistacia lentiscus: phytochemistry and antidiabetic properties. Nutrients. 2024. https://pubmed.ncbi.nlm.nih.gov/38892571/
- Alwadi MAM, Sidhu A, Khaled MB, Aboul-Enein BH. Mastic (Pistacia lentiscus) gum and oral health: a state-of-the-art review of the literature. Journal of Natural Medicines. 2023. https://pubmed.ncbi.nlm.nih.gov/37147480/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
